A detailed history of Black Rock Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 3,219,649 shares of SAVA stock, worth $84.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,219,649
Previous 3,045,464 5.72%
Holding current value
$84.2 Million
Previous $61.8 Million 35.65%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.35 - $26.11 $2.15 Million - $4.55 Million
174,185 Added 5.72%
3,219,649 $39.8 Million
Q1 2024

May 10, 2024

BUY
$18.44 - $26.41 $148,423 - $212,574
8,049 Added 0.26%
3,045,464 $61.8 Million
Q4 2023

Feb 13, 2024

BUY
$12.64 - $30.11 $2.51 Million - $5.97 Million
198,431 Added 6.99%
3,037,415 $68.4 Million
Q3 2023

Nov 13, 2023

BUY
$16.64 - $25.32 $1.53 Million - $2.33 Million
92,076 Added 3.35%
2,838,984 $47.2 Million
Q2 2023

Aug 11, 2023

BUY
$21.59 - $27.88 $2.68 Million - $3.46 Million
124,231 Added 4.74%
2,746,908 $67.4 Million
Q1 2023

May 12, 2023

BUY
$23.46 - $36.44 $1.36 Million - $2.12 Million
58,149 Added 2.27%
2,622,677 $63.3 Million
Q4 2022

Feb 13, 2023

BUY
$27.82 - $44.16 $2.19 Million - $3.48 Million
78,807 Added 3.17%
2,564,528 $75.8 Million
Q3 2022

Nov 14, 2022

SELL
$16.33 - $51.06 $2.87 Million - $8.99 Million
-175,999 Reduced 6.61%
2,485,721 $104 Million
Q2 2022

Aug 12, 2022

SELL
$17.22 - $38.47 $726,012 - $1.62 Million
-42,161 Reduced 1.56%
2,661,720 $74.8 Million
Q1 2022

May 12, 2022

SELL
$32.6 - $53.05 $1.86 Million - $3.03 Million
-57,097 Reduced 2.07%
2,703,881 $100 Million
Q4 2021

Feb 10, 2022

BUY
$36.77 - $90.91 $5.78 Million - $14.3 Million
157,100 Added 6.03%
2,760,978 $121 Million
Q3 2021

Nov 09, 2021

BUY
$41.79 - $135.3 $6.35 Million - $20.6 Million
151,999 Added 6.2%
2,603,878 $162 Million
Q2 2021

Aug 11, 2021

BUY
$32.15 - $89.72 $78.8 Million - $220 Million
2,451,879 New
2,451,879 $209 Million

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.05B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.